Juvenile Dermatomyositis Clinical Trial
Official title:
Efficacy and Safety of Creatine Supplementation in Patients With Juvenile Systemic Lupus Erythematosus and Juvenile Dermatomyositis
Creatine supplementation may improve strength, muscle mass, bone mass and muscle function in healthy and elderly people. The investigators speculate that creatine supplementation could have therapeutic effects in pediatric rheumatic (i.e., juvenile systemic lupus erythematosus and juvenile dermatomyositis) patients who usually present muscle weakness, muscle wasting and bone mass loss.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05545839 -
Transition to Adulthood Through Coaching and Empowerment in Rheumatology
|
N/A | |
Recruiting |
NCT05524311 -
Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)
|
Phase 2 | |
Recruiting |
NCT00059748 -
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
|
||
Completed |
NCT00323960 -
Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis
|
Phase 3 | |
Completed |
NCT02267005 -
The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis
|
N/A | |
Completed |
NCT00106184 -
Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
|
Phase 2 | |
Completed |
NCT02245841 -
Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis
|
Phase 4 | |
Completed |
NCT03430388 -
Yellow Fever Vaccine in Patients With Rheumatic Diseases
|
N/A | |
Completed |
NCT05509140 -
Clinical Analysis of Juvenile Dermatomyositis Patients
|
||
Recruiting |
NCT01276470 -
Environmental Risk Factors for the Anti-synthetase Syndrome
|
||
Recruiting |
NCT03433638 -
Juvenile Dermatomyositis
|
N/A | |
Recruiting |
NCT03432455 -
Incidence and Prevalence of Juvenile Dermatomyositis
|
N/A | |
Completed |
NCT00815282 -
Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease
|
Phase 4 | |
Completed |
NCT01697254 -
The CARRA Registry
|
N/A |